Pictet Asset Management Ltd. Cuts Holdings in Express Scripts Holding Co (ESRX)

Pictet Asset Management Ltd. decreased its position in Express Scripts Holding Co (NASDAQ:ESRX) by 7.3% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 294,760 shares of the company’s stock after selling 23,200 shares during the period. Pictet Asset Management Ltd. owned about 0.05% of Express Scripts worth $28,005,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ESRX. American National Registered Investment Advisor Inc. increased its holdings in shares of Express Scripts by 6.9% during the 3rd quarter. American National Registered Investment Advisor Inc. now owns 7,825 shares of the company’s stock worth $743,000 after acquiring an additional 505 shares during the last quarter. Bank of Stockton increased its holdings in shares of Express Scripts by 5.2% during the 3rd quarter. Bank of Stockton now owns 11,821 shares of the company’s stock worth $1,123,000 after acquiring an additional 581 shares during the last quarter. Busey Trust CO increased its holdings in shares of Express Scripts by 0.5% during the 3rd quarter. Busey Trust CO now owns 114,461 shares of the company’s stock worth $10,874,000 after acquiring an additional 617 shares during the last quarter. Strategic Advisors LLC increased its holdings in shares of Express Scripts by 11.2% during the 3rd quarter. Strategic Advisors LLC now owns 6,201 shares of the company’s stock worth $589,000 after acquiring an additional 623 shares during the last quarter. Finally, Bessemer Group Inc. increased its holdings in shares of Express Scripts by 3.9% during the 3rd quarter. Bessemer Group Inc. now owns 18,940 shares of the company’s stock worth $1,800,000 after acquiring an additional 717 shares during the last quarter. Hedge funds and other institutional investors own 85.02% of the company’s stock.

A number of research analysts recently weighed in on ESRX shares. Zacks Investment Research reissued a “buy” rating and set a $109.00 target price on shares of Express Scripts in a report on Tuesday, November 13th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, September 17th. Cowen reissued a “buy” rating and set a $88.00 target price on shares of Express Scripts in a report on Friday, November 2nd. Credit Suisse Group lowered Express Scripts from an “outperform” rating to a “neutral” rating and boosted their target price for the stock from $90.00 to $96.50 in a report on Tuesday, September 18th. Finally, Royal Bank of Canada set a $101.00 target price on Express Scripts and gave the stock a “buy” rating in a report on Thursday, November 1st. One research analyst has rated the stock with a sell rating, fourteen have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $90.60.

In other news, Director Mahon Thomas P. Mac sold 5,234 shares of the stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $99.50, for a total transaction of $520,783.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.79% of the company’s stock.

Shares of NASDAQ ESRX opened at $101.47 on Monday. The company has a current ratio of 0.77, a quick ratio of 0.65 and a debt-to-equity ratio of 0.63. Express Scripts Holding Co has a one year low of $61.30 and a one year high of $101.71. The firm has a market capitalization of $57.21 billion, a price-to-earnings ratio of 14.29, a PEG ratio of 1.28 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Wednesday, October 31st. The company reported $2.43 EPS for the quarter, beating analysts’ consensus estimates of $2.42 by $0.01. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The firm had revenue of $25.56 billion for the quarter, compared to analyst estimates of $25.11 billion. During the same period in the prior year, the firm posted $2.51 EPS. The company’s revenue for the quarter was up 3.6% on a year-over-year basis. Equities analysts forecast that Express Scripts Holding Co will post 9.08 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Pictet Asset Management Ltd. Cuts Holdings in Express Scripts Holding Co (ESRX)” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this story can be viewed at https://www.com-unik.info/2018/12/03/pictet-asset-management-ltd-cuts-holdings-in-express-scripts-holding-co-esrx.html.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Further Reading: Benefits of owning preferred stock

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit